FindTrial
Sign In

Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections

A Comparative Study of Postoperative Analgesia of Different Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04747171
Enrollment
105
Registered
2021-02-10
Start date
2021-04-30
Completion date
2021-07-31
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

we designed this randomized, single -blind, prospective clinical study to test postoperative analgesia of three intrathecal additives in elective caesarean sections which are magnesium, dexamethasone and dexmedetomidine.

Interventions

DRUGintrathecal Magnesium

intrathecal adjuvants to bupivacaine

DRUGintrathecal dexamthasone

intrathecal adjuvants to bupivacaine

DRUGintrathecal dexmedetomidine

intrathecal adjuvants to bupivacaine

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old ) * Elective cesarean section under spinal anaesthesia * Gestational age \> 37 weeks * BMI less than 30 kg/m2

Exclusion criteria

* Patient refusal * unable to give consent * age \< 18 or \> 40 * BMI more than 30 kg/m2 * known allergy to the study medication * coagulopathies or on anticoagulant medications * diabetic neuropathy * patients with psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
analgesic effectUp to 24 hours after surgeryduration of sensory block

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026